Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEEL: Pink vs. White pMDI Actuators on Asthma Symptoms Perception
NCT04886999Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Feb 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate and formoterol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Change From Baseline in Average VAS Score Perceptions of Asthma - Over the Entire 14-day Treatment Period - Question #3. Started Feb 2022; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04886999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04886999.